TMO NYSE
Credit Risk of going bust: lower than 79% of companies Debt: 14.0% of company value Bonds: $454.1M held by 353 funds, 52 bp over Treasuries → details ▾
If the stock fell to about $7.50 (down 99%), Thermo Fisher Scientific Inc. would be worth roughly what it owes.
Total debt $41.37B against a stock market value of $253.24B.
Distance to default 9.42 (Merton model): prices to 2026-10-26, balance sheet 2026-09-26, debt counted $21.82B (short-term plus half of long-term), stock volatility 29.2%; Altman Z'' 2.15. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Waltham, MA 02451
US
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| WEISLER DION J | A-Award | 56 | — | 2026-09-26 |
| SPERLING SCOTT M | A-Award | 63 | — | 2026-09-26 |
| Lynch Karen S | A-Award | 46 | — | 2026-09-26 |
| Keith R. Alexandra | A-Award | 46 | — | 2026-09-26 |
| JOHNSON JENNIFER M | A-Award | 46 | — | 2026-09-26 |